Global Oncology Launches Global Cancer Project Map To Improve Cancer Control Worldwide in Collaboration with NCI
![](/46/pdcnewsitem/03/43/19/83dOtojDDIcoCgC.png)
Nonprofit Global Oncology GO) has launched the Global Cancer Project Map, a first-of-its-kind online resource and virtual information exchange for connecting the global cancer community. Developed by GO in collaboration with the National Cancer Institute (NCI) Center for Global Health, the Map enables worldwide access to cancer projects and expertise to improve cancer practices and patient outcomes, especially in low-resource settings.
The Map was unveiled at the Symposium on Global Cancer Research, which is sponsored by NCI, the Consortium of Universities for Global Health (CUGH), and the Dana-Farber Cancer Institute, and is taking place in Boston, MA.
GO developed the Global Cancer Project Map to fill a crucial need for shared resources: According to the World Bank, only 5% of global health funding for cancer is committed to oncology in developing countries. This number stands even though Africa, Asia, and Central and South America account for 60% of the world’s new cancer diagnoses and 70% of the world’s cancer deaths, according to the World Health Organization.
“The Map is an important and innovative step forward in our effort to reduce health disparities and strengthen human capital in underserved areas of the world,” said Michele Barry Director of Stanford University’s Center for Innovation in Global Health. “With cancer rates rapidly increasing in low-resource settings, the Map creates a place where the global cancer community can share and access information that is critical to providing better treatment and care.”
The Global Cancer Project Map is an interactive online database that allows users to search for cancer experts and research projects by country and by cancer type, and then to initiate contact with project principal investigators and programme directors. The Map launched with more than 700 projects spanning six continents. The goal is for the Map to grow exponentially as awareness builds and an online tool is added in late 2015 allowing users to upload projects directly.
The Global Cancer Project Map covers a wide range of projects, from cancer prevention and screening to capacity training, clinical programs and palliative care. Illustrative projects include
• Improving diagnostic accuracy of mammograms for breast cancer in Turkey through new methods
• Preventing arsenic-induced skin cancer in Bangladesh through the study of vitamin E and selenium supplementation
• Creating an early screening test for gastric cancer in Mexico through biomarker identification leading to an early screening test.
According to Dr Ted Trimble, director of NCI’s Center for Global Health, though many dedicated researchers and caregivers are conducting groundbreaking cancer programmes around the world, until today they could not reference the collective knowledge and experiences of their colleagues in one central place. The Global Cancer Project Map has been highly anticipated in the cancer community and will make a significant impact in cancer patient care and global health.
“Before it was difficult or often impossible to find information about cancer projects or experts, especially in resource-limited settings,” said GO co-founder Ami S. Bhatt, Assistant Professor, Stanford University. “The Map now makes it possible to connect colleagues in the global cancer community with a maximum of six clicks of a computer mouse.”
“We have the ambitious goal of providing access to every cancer research, care, and outreach programme in the world through the Map,” said GO co-founder Franklin W. Huang, Instructor at Dana-Farber Cancer Institute and Harvard Medical School. “GO encourages anyone working in cancer to use the Map to get and give valuable information about their projects, contributing to cancer care for patients no matter where they are.”
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance